Noorhayati M. Nasir joined Xeraya Capital in August 2016. Prior to Xeraya, she was the Vice President, Business Development and Investment – Healthcare at the Malaysian Biotechnology Corporation Sdn Bhd (BiotechCorp).

Noorhayati has 10 years of experience working on investments in the life sciences, specifically the healthcare sector, with economic development initiatives her primary concern. At Malaysian Biotechnology Corporation, she was responsible for assessing business proposals for grant and incentive applications, advising and facilitating investors in due diligence, business model structuring, business matching, government relations and project implementation. As part of the pioneer team in the Healthcare Business Development and Investment Unit, she successfully supported multiple investments into Malaysia in various subsectors under healthcare.

Noorhayati was heavily involved in creating links between international companies and local universities to promote industry-academia partnerships, fostering innovation and commercialisation.

Whilst at BiotechCorp, Noorhayati was part of various policy development roundtable discussions and was appointed as the Core Team Member for the Horizon Scanning Committee under the Health Technology Assessment Unit in Ministry of Health (MOH) Malaysia, offering technical advice on new and emerging health technologies.

Noorhayati holds a Bachelor of Science degree majoring in Biotechnology from University Malaya and an MBA in International Business from University Putra Malaysia.